Evidence map›Paper›PMID 23249093›Full record

ReviewAutoimmunity2013

Somatic mutagenesis in autoimmunity.

Thiago Detanico, James B St Clair, Katja Aviszus, Greg Kirchenbaum, Wenzhong Guo, Lawrence J Wysocki

Abstract readReview
In one paragraph

Review in Autoimmunity, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. B cell checkpoints in autoimmune rheumatic diseases.Nature reviews. Rheumatology · 2019
    Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. T cells in Systemic Lupus Erythematosus.Current opinion in immunology · 2016
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Thiago DetanicoIntegrated Department of Immunology, National Jewish Health and University of Colorado School of Medicine, Denver, CO 80206, USA.
James B St Clair
Katja Aviszus
Greg Kirchenbaum
Wenzhong Guo
Lawrence J Wysocki
University of Colorado Denver · USNational Jewish Health · US

Funding

Medical Scientist Training ProgramT32GM008497 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI WILSON, CARA C. · 1993 to 2022
$15.2M
IMMUNE RECOGNITION AND TOLERANCE OF ANTIBODY DIVERSITYR01AI033613 · NIAID · NATIONAL JEWISH HEALTH · PI WYSOCKI, LAWRENCE J · 1993 to 2009
$2.7M
Somatic Hypermutation in SLER01AI093822 · NIAID · NATIONAL JEWISH HEALTH · PI WYSOCKI, LAWRENCE J · 2012 to 2016
$2.0M
Functional Anergy in B CellsR01AI073945 · NIAID · NATIONAL JEWISH HEALTH · PI WYSOCKI, LAWRENCE J · 2008 to 2012
$1.9M
A Reporter for Mutant Autoreactive B CellsR03AI088408 · NIAID · NATIONAL JEWISH HEALTH · PI WYSOCKI, LAWRENCE J · 2010 to 2011
$155k
Autoantibody and BCR peptide-specific T cells in lupus nephritisF30DK091102 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI ST CLAIR, JAMES BEN · 2011 to 2014
$142k
NIAID NIH HHS R01 AI033613NIAID NIH HHS R01AI033613NIAID NIH HHS R01 AI073945NIAID NIH HHS R01AI073945NIAID NIH HHS R01 AI093822NIAID NIH HHS R01AI093822NIAID NIH HHS R03 AI088408NIDDK NIH HHS 1F30 DK091102NIDDK NIH HHS F30 DK091102NIGMS NIH HHS T32 GM008497
6 · The paper itself

Abstract

Our laboratory investigates systemic autoimmune disease in the context of mouse models of systemic lupus erythematosus (SLE). SLE is associated with high titers of serum autoantibodies of the IgG class that are predominantly directed against nuclear antigens, with pathological manifestations that are considered by many to be characteristic of an immune-complex mediated disease. In this review, we focus on the known and potential roles of somatic mutagenesis in SLE. We will argue that anti-nuclear antibodies (ANA) arise predominantly from nonautoreactive B cells that are transformed into autoreactive cells by the process of somatic hypermutation (SHM), which is normally associated with affinity maturation during the germinal center reaction. We will also discuss the role of SHM in creating antigenic peptides in the V region of the B cell receptor (BCR) and its potential to open an avenue of unregulated T cell help to autoreactive B cells. Finally, we will end this review with new experimental evidence suggesting that spontaneous somatic mutagenesis of genes that regulate B cell survival and activation is a rate-limiting causative factor in the development of ANA.

Indexed as

Somatic Hypermutation, ImmunoglobulinAnimalsAntibodies, AntinuclearAutoimmunityB-LymphocytesHumansMiceT-LymphocytesAntibodies, Antinuclear

Identifiers

PMID23249093
PMCPMC3743419
OpenAlexW2041226615

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.